Respiratory devices are medical equipment used for the treatment, monitoring, and diagnosis of respiratory diseases and conditions. Key devices include ventilators, oxygen concentrators, nebulizers, inhalers, and monitoring devices. The rising prevalence of respiratory diseases such as COPD and asthma is increasing the demand for long-term oxygen therapy, home care ventilators, and portable nebulizers. Technological advancements are enabling devices to become more compact, portable, and easy to use.
The global respiratory devices market is estimated to be valued at USD 23.58 Bn in 2024 and is expected to reach USD 48.94 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11% from 2024 to 2031.
Key Takeaways
Key players operating in the Respiratory Devices market are TCS, Wipro, Cognizant, Infosys, IBM, Qualitest, CGI, Mindtree, Cygnet Infotech, Maveric Systems, QA Mentor, A1QA, QA Source, QASource, Capgemini, Accenture, HCL Technologies, Atos, DXC Technology, Tech Mahindra. The major players are focusing on developing innovative and smart respiratory devices. For instance, ventilators are being integrated with sensors and data analytics capabilities for remote monitoring.
The growing geriatric population is increasing the Respiratory Devices Market Demand for home healthcare devices. Portable oxygen concentrators and nebulizers allowing independent living are gaining more traction. Rising pollution levels and changing lifestyles have led to a surge in asthma and COPD cases. This has opened up opportunities for personalized respiratory care devices and prescription-based emergency inhalers.
Technological advancements such as integrated sensors, Bluetooth connectivity, and mobile compatibility are enabling remote monitoring of patients. AI and predictive analytics are being used to process breathing patterns and trigger alerts in case of deterioration. Compact designs and long battery life allow continuous monitoring outside hospitals.
Market Drivers
The increasing healthcare expenditure on respiratory care devices especially in developing nations is a key growth driver. According to the WHO, respiratory diseases account for over 8% of total global healthcare expenditure. Favorable reimbursement policies for home healthcare are encouraging patients to opt for respiratory devices. Rising lifestyle diseases, tobacco/air pollution exposure, and aging population have increased the risk of various respiratory ailments. This is propelling the demand for respiratory devices for treatment and management.
Get more insights on Respiratory Devices Market